3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Advanced Breast Cancer
1
Interventions
Doxorubicin
26
pembrolizumab
24
Radiotherapy
20
Cyclophosphamide
18
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Nivolumab
14
Gemcitabine
13
Ifosfamide
12
Surgical Procedures, Operative
11
Biopsy
11
Radiation
10
X-Rays
8
Temozolomide
8
Ipilimumab
8
pazopanib
7
fludarabine
7
cabozantinib
7
Irinotecan
7
tazemetostat
6
liposomal doxorubicin
6
Trabectedin
6
Surveys and Questionnaires
6
Phantoms, Imaging
6
Blood Specimen Collection
6
olaparib
5
eribulin
5
atezolizumab
5
anlotinib
5
Vincristine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Ritonavir
×
1 year
×
Clear all
No trials found.